Gilead Sciences GILD
NASDAQ GILD
$143.72 -1.09 (-0.75%)
As of: Sep 11, 2026 · 3:59 PM EDT

Gilead Sciences (GILD) Change in Taxes (2009 - 2026)

Gilead Sciences' (GILD) quarterly Change in Taxes came in at $171.0 million in Q2 2026, up 113.15% on a YoY basis from $80.2 million in Q2 2025, and up 689.66% quarter-over-quarter from -$29.0 million in Q1 2026.

Analysis

Gilead Sciences (GILD) Change in Taxes (2009 - 2026) Analysis & Trends

Gilead Sciences (GILD) has reported Change in Taxes for 18 consecutive years, with $171.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Taxes rose 113.15% year-over-year to $171.0 million; the trailing twelve-month figure through Jun 2026 stood at -$114.0 million (up 90.54% YoY), and the FY2025 full-year result was -$2.1 billion, down 187.98% from the prior year.
  • Change in Taxes climbed to $171.0 million in Q2 2026 per GILD's latest filing, from -$29.0 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $536.0 million in Q4 2024 and bottomed at -$1.3 billion in Q2 2025.
  • Historically, Change in Taxes has averaged -$268.3 million across 5 years, with a median of -$128.0 million in 2025.
  • The widest YoY moves for Change in Taxes: up 176.79% in 2024, down 4082.14% in 2024.
  • Over 5 years, Change in Taxes stood at $119.0 million in 2022, then plunged by 686.55% to -$698.0 million in 2023, then surged by 176.79% to $536.0 million in 2024, then sank by 125.0% to -$134.0 million in 2025, then surged by 227.61% to $171.0 million in 2026.
  • According to Business Quant data, Change in Taxes over the past three periods registered $171.0 million, -$29.0 million, and -$134.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -131.00 Mn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 171.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 13.80 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -10.18 Mn
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171.00 Mn
Mar 31, 2026 -29.00 Mn
Dec 31, 2025 -134.00 Mn
Sep 30, 2025 -122.00 Mn
Jun 30, 2025 -1.30 Bn
Mar 31, 2025 -552.00 Mn
Dec 31, 2024 536.00 Mn
Sep 30, 2024 111.00 Mn
Jun 30, 2024 -1.17 Bn
Mar 31, 2024 -208.00 Mn
Dec 31, 2023 -698.00 Mn
Sep 30, 2023 -881.00 Mn
Jun 30, 2023 -28.00 Mn
Mar 31, 2023 -161.00 Mn
Dec 31, 2022 119.00 Mn
Sep 30, 2022 108.00 Mn
Jun 30, 2022 -479.00 Mn
Mar 31, 2022 -112.00 Mn
Dec 31, 2021 102.00 Mn
Sep 30, 2021 72.00 Mn